Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI

Episode 52 April 23, 2025 00:52:05
Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI

Apr 23 2025 | 00:52:05

/

Show Notes

How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far Between podcast!

Host Chris O'Brien welcomes Joshua Kresh, Emily Michiko Morris, and Mark Schultz from IPPI: The Intellectual Property Policy Institute. Tune in for a fascinating discussion on the dos and don'ts of IP protection.

Listen to the latest episode today!

Other Episodes

Episode 7

August 04, 2021 00:38:14
Episode Cover

Episode 7: US Congressman Gus Bilirakis

On today's podcast, US Congressman Gus Bilirakis joins host Wayne Bowden to discuss the importance of rare disease awareness and treatment.

Listen

Episode 23

September 14, 2022 00:37:26
Episode Cover

Episode 23: Dr. Arun Bhatt, Consultant for Clinical Research and Drug Development in India

What makes India a smart and viable setting for today’s clinical trials? Join us for the latest episode of Few & Far Between. Biorasi's ...

Listen

Episode 37

January 24, 2024 00:41:31
Episode Cover

Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche

"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...

Listen